All In MedTech

FDA Clearance Tracker · P030016-S045

EVO Visian Implantable Collamer Lens for Myopia (VICMO), EVO Visian Toric Implantable Collamer Lens for Myopia (VTICMO),

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Oct 1, 2024 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Oct 1, 2024

Approved

Time to decision

172 days

Received Apr 12, 2024. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P030016-S045
Device name
EVO Visian Implantable Collamer Lens for Myopia (VICMO), EVO Visian Toric Implantable Collamer Lens for Myopia (VTICMO),
Applicant location
Monrovia, CA
Received
Apr 12, 2024
Decided
Oct 1, 2024
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Labeling Change - Indications/instructions/shelf life/tradename
Original approval
P030016

Device type

Device class
Class III
Specialty
Ophthalmology

Every decision under product code MTA

FDA's approval statement

As written in FDA's record.

approval for labeling updates related to PAS “CP22-01 Postmarket Evaluation of the EVO ICL"

Source documents

Other decisions for STAAR Surgical Company

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

1 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.